Due to maintenance work, this service and ftp://ftp.expasy.org will be unavailable from Tuesday August 23rd 18:00 until Wednesday August 24th 08:00
CEST . Apologies for the inconvenience.
UniProtKB/Swiss-Prot Q9Y282 : Variant p.Ile113Leu
Endoplasmic reticulum-Golgi intermediate compartment protein 3
Gene: ERGIC3
Variant information
Variant position: 113 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: LB/BThe variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change: From Isoleucine (I) to Leucine (L) at position 113 (I113L, p.Ile113Leu).Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Similar physico-chemical property. Both residues are medium size and hydrophobic.The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: 2The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Other resources: Links to websites of interest for the variant.
Sequence information
Variant position: 113 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 383 The length of the canonical sequence.
Location on the sequence:
GEQQLDVEHNLFKQRLDKDG
I PVSSEAERHELGKVEVTVFD
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GEQQLDVEHNLFKQRLDKDGI PVSSEAE-RHELGKVEVTV-FD
Mouse GEQQLDVEHNLFKKRLDKDGV PVSSEAE-RHELGKVEVTV-
Bovine GEQQLDVEHNLFKKRLDKDGF PVSSEAE-RHELGKVEVKV-
Xenopus laevis GEQQLDVEHNLFKQRLDLDKK PVTSEAD-RHELGKSEEQVV
Xenopus tropicalis GEQQLDVEHNLFKQRLDKDKK PVTSEAD-RHELGKSEEHVV
Zebrafish GEQQLDVEHNLFKQRLDKDGQ PVTTEAE-KHDLGKEEEGV-
Slime mold GEHQFDVAHNIFKKRLSPTGQ PIIEAPPIREEEINKKESV-
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 383
Endoplasmic reticulum-Golgi intermediate compartment protein 3
Topological domain
47 – 341
Lumenal
Modified residue
116 – 116
Phosphoserine
Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.